AzTrials
AzTrials

CounterstrainNCT05226611

The Effect of Counterstrain Technique on Muscle Stiffness and Pain on Trapezius Tender Points in Medical Students

A study testing Counterstrain in people with Counterstrain and MyotonPRO, run by New York Institute of Technology at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Medical students are prone to developing neck pain due to prolonged studying and poor posture. This can manifest as tender points in the upper trapezius region. Counterstrain (CS) is an osteopathic manipulative technique that has shown efficacy in previous studies in treating tender points. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Counterstrain, MyotonPRO, Tender Points
What is being tested?
Counterstrain
Could I receive a placebo?
No, everyone receives an active treatment
How many people
27 participants
Where
1 siteUnited States
Study dates
10 Mar 2021to 14 Apr 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Subject is at least 18 years of age

Who cannot join

  • Traumatized (sprained or strained) tissues, which would be negatively affected by the positioning of the patient
  • Illness or other conditions in which strict positional restrictions preclude treatment
  • Instability of the area being positioned that has the potential to produce unwanted neurologic or vascular side effects
  • Vascular or neurologic syndromes, such as basilar insufficiency or neural foraminal compromise whereby the position of treatment has the potential to exacerbate the condition
  • Severe degenerative spondylosis with local fusion and no motion at the level where treatment positioning would normally take place
  • Pregnancy
  • Positive for COVID-19 as well as symptoms indicating a SARS-CoV-2 infection

Trial locations and contacts

1 site in 1 country.

United States1 site
  • NYIT College of Osteopathic Medicine

    Glen Head, New York, 11545

Other trials in United States

About this study

Medical students are prone to developing neck pain due to prolonged studying and poor posture. This can manifest as tender points in the upper trapezius region. Counterstrain (CS) is an osteopathic manipulative technique that has shown efficacy in previous studies in treating tender points. The MyotonPRO is a myotonometric device that can be used to measure various muscle parameters such as muscle stiffness. There is limited research regarding the use of osteopathic manipulative medicine to produce measurable changes in muscle stiffness by the MyotonPRO. This educational study aims to establish the efficacy of CS technique in decreasing the pain level of upper trapezius tender points in medical students as well as determining if CS causes a significant decrease in muscle stiffness in treated tender points as measured by the MyotonPRO. The investigators hope this educational study will encourage further studies on how osteopathic manipulative techniques affects the physiologic parameters of muscles.

Being tested
Counterstrain
Keywords
Counterstrain, MyotonPRO, Tender points, Medical Students

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CounterstrainOther

    Counterstrain is a hands-on OMM technique that involves shortening the muscle to resolve the dysfunctional muscle stretch reflex and holding it for 90 seconds. The patient is then brought back to a neutral position and reassessed.

Study groups in NCT05226611
Study groupRoleWhat they receive
Tender point treatment with CounterstrainExperimentalA tender point was located in the upper trapezius region of the test subject and treated with counterstrain. The side with the highest initial pain level was used as the treatment side. Pain level was measured before and after treatment. The MyotonPRO was also used to measure physiologic parameters of the muscle before and after treatment.
Receives: Other: Counterstrain

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain level

    Pain level of the tender point as rated by the test subject out of a scale of 1 to 10, 1 being very little pain and 10 being the most pain the test subject has ever felt.

    Measured: This was done immediately before and immediately after counterstrain treatment. Counterstrain treatment is a hands-on osteopathic manipulative technique that involves shortening the muscle belly of the painful region.

Secondary outcomes (1)
  1. Muscle Stiffness

    Muscle stiffness measured by the MyotonPRO, a myotonometric device that applies a brief mechanical impulse to the targeted muscle, used to measure physiologic parameters such as muscle stiffness.

    Measured: This was done immediately before and immediately after counterstrain treatment. Counterstrain treatment is a hands-on osteopathic manipulative technique that involves shortening the muscle belly of the painful region.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Feb 2022
  2. Study start10 Mar 2021
  3. Primary completion14 Apr 2021
  4. Study completion14 Apr 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
27 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05226611
Sponsor's protocol ID
#BHS-1561
Status last verified
Jan 2022
First submitted
12 Jan 2022
Last updated
7 Feb 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Counterstrain in people with Counterstrain and MyotonPRO, run by New York Institute of Technology at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain level (time frame: This was done immediately before and immediately after counterstrain treatment. Counterstrain treatment is a hands-on osteopathic manipulative technique that involves shortening the muscle belly of the painful region.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in